Analystreport

Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) had its price target lowered by analysts at Piper Jaffray Companies from $8.00 to $7.00.

Catalyst Pharmaceuticals, Inc.  (CPRX) 
Last catalyst pharmaceuticals, inc. earnings: 3/16 05:26 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.catalystpharma.com